|
|
 Larger image
|
List Price: N/A
Our Price: $295.00
Availability: Usually ships in 2 to 4 weeks
Manufacturer: Finadco
|
Average Customer Rating:  
|
|
Binding: Magazine
First Issue Lead Time: 2-4
Format: Newspaper Subscription
Issues Per Year: 252
Label: Finadco
Magazine Type: Trade magazine
Manufacturer: Finadco
Number Of Issues: 252
Publisher: Finadco
Studio: Finadco
Subscription Length: 365
|
|
|
|
|
|
|
|
|
Editorial Reviews:
|
Newspaper covering companies, industries, potentially successful stocks, and developments in the economy, as well as providing analysis of national news stories.
|
|
|
| Spotlight customer reviews: |
|
Customer Rating:
Summary: IBD does a good job
Comment: When looking for info on the world of stocks and bonds the IBD is a good place to start.
Customer Rating:
Summary: Good Stock Newspaper but very reactionary
Comment: This is a good newspaper with TONS of financial data on individual stocks. But their recommendations are typically very reactionary and are pure momentum picks(where the stock has already appreciated substantially). Rarely are there any sort of contrarian picks or stock that have not already moved a good percentage in price.
Also, as has been mentioned before, their editorials are so right-wing that it makes for nothing more than sensational comedy.
Customer Rating:
Summary: Great paper for Investing
Comment: This is a great paper for investors who like to do research. It is not a paper for editorial content. I found IBD's investment approach very logical. They give you all the data you need to find quality stocks. I have never read the editorials because their reputation. If I want editorial content I will go to newspapers or magazines.
Customer Rating:
Summary: Worth the Price/Ignore the Editorials if You Like
Comment: The advice given in IBD is tremendously useful to both the novice investor and to the more seasoned investor. Following the CAN SLIM rules set forth by IBD along with the rules for investment success that IBD provides will enable you to be successful in your investment endeavors. The IBD 100 is a useful tool in which IBD ranks the top 100 stocks, based on fundamentals, etc. Obviously, the editorials prove to be controversial. If you're interested in making money and you don't agree with the views of the staff, simply don't read that page. I don't and I make money. If you want to ignore this paper simply because of its conservative viewpoints, you are probably doing yourself a great disservice. Yes, there are cheaper financial newspapers out there. The point; however, is not what you put into something--it's what you get out of it. The return on investment can be astounding if you let it.
Customer Rating:
Summary: Useful Investment Info, But Misguided Editorializing
Comment: IBD is a useful investment tool, and Bill O'Neil's investment approach is one that a person can employ profitably.
Sadly, and as other reviewers have rightly noted, IBD's editorializing is both extreme and often seems to lack a careful analysis of the facts on any given issue (the facts being our one path to the truth).
Please, Bill O'Neil, when even conservative George Will can rightly criticize George W. Bush's foreign policy, when eminent scientists around the world state that it is 90% certain that humans are warming the planet, etc., don't stick your head in the sand and deny reality. Such positions are askew of the facts and reflect, too often, a selfish posture.
A more careful analysis of reality would lead to more tempered editorials (in most cases) and a more esteemed publication. Here's hoping that IBD moves in that direction.
|
|
|
|
|
|
|
|
|
|
|
|
|
